# Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cardiovascular-toxicity-of-tyrosine-kinase-inhibitors-used-in-chronic-myeloid/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Santa Cirmi,Asmae El,Louis Létinier,Michele Navarra,Francesco Salvo |
| Citations | 145 |
| DOI | 10.3390/cancers12040826 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2072-6694/12/4/826/pdf?version=1585556924 |
| OpenAlex ID | https://openalex.org/W3013082751 |
| PMID | 32235443 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Michele Navarra](https://scholariq.org/researchers/michele-navarra/)

## Paper journal

- [Cancers](https://scholariq.org/journals/cancers/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.